T1	disease_or_phenotypic_feature 33 41	cataract
T2	chemical 80 91	factor VIII
T3	chemical 92 101	inhibitor
T4	disease_or_phenotypic_feature 144 152	cataract
T5	chemical 209 218	oxidation
T6	disease_or_phenotypic_feature 244 252	cataract
T7	chemical 293 300	oxidant
T8	disease_or_phenotypic_feature 313 321	cataract
T9	chemical 350 357	antigen
T10	chemical 381 384	DCs
T11	disease_or_phenotypic_feature 421 427	cancer
T12	disease_or_phenotypic_feature 472 478	autism
T13	chemical 494 503	serotonin
T14	chemical 513 523	inhibitors
T15	chemical 525 534	Diosmetin
T16	disease_or_phenotypic_feature 594 605	skin cancer
T17	chemical 607 617	Anesthesia
T18	chemical 649 664	succinylcholine
T19	disease_or_phenotypic_feature 682 708	Smith-Lemli-Opitz syndrome
T20	disease_or_phenotypic_feature 713 735	malignant hyperthermia
T21	chemical 745 749	food
T22	disease_or_phenotypic_feature 776 783	obesity
T23	chemical 793 801	Miglitol
T24	chemical 833 837	drug
T25	disease_or_phenotypic_feature 846 853	obesity
T26	chemical 875 887	somatostatin
T27	chemical 902 919	dopamine agonists
T28	disease_or_phenotypic_feature 940 949	pituitary
T29	disease_or_phenotypic_feature 959 967	Diplopia
T30	disease_or_phenotypic_feature 974 982	cataract
T31	chemical 1048 1058	anesthesia
T32	chemical 1084 1090	oxygen
T33	disease_or_phenotypic_feature 1123 1131	cataract
T34	chemical 1152 1162	anesthesia
T35	chemical 1179 1186	mineral
T36	disease_or_phenotypic_feature 1187 1207	metabolism disorders
T37	disease_or_phenotypic_feature 1211 1224	renal failure
T38	chemical 1233 1236	MYC
T39	chemical 1237 1246	inhibitor
T40	disease_or_phenotypic_feature 1277 1292	prostate cancer
T41	chemical 1301 1310	Tamoxifen
T42	chemical 1353 1361	estrogen
T43	chemical 1393 1401	estrogen
T44	chemical 1402 1409	agonist
T45	disease_or_phenotypic_feature 1443 1456	breast cancer
T46	disease_or_phenotypic_feature 1495 1513	growth retardation
T47	chemical 1599 1603	drug
T48	chemical 1625 1635	antagonist
T49	chemical 1636 1659	1,3,7-trimethylxanthine
T50	chemical 1661 1669	caffeine
T51	chemical 1695 1701	sodium
T52	chemical 1705 1714	potassium
T53	disease_or_phenotypic_feature 1726 1733	obesity
T54	chemical 1764 1775	biochemical
T55	disease_or_phenotypic_feature 1787 1795	cataract
T56	chemical 1829 1834	metal
T57	chemical 1838 1843	metal
T58	chemical 1844 1847	THA
T59	disease_or_phenotypic_feature 1865 1878	renal failure
T60	disease_or_phenotypic_feature 1911 1929	cervical carcinoma
T61	chemical 1975 1981	oxygen
T62	chemical 2001 2008	antigen
T63	chemical 2045 2053	bombesin
T64	chemical 2063 2069	ligand
T65	disease_or_phenotypic_feature 2166 2181	prostate cancer
T66	missed_disease_or_phenotypic_feature 164 182	lens opacification
T67	missed_chemical 275 279	H2O2
T68	missed_chemical 111 115	H2O2
R1	causes_or_contributes_to Arg1:T68 Arg2:T66	
R2	causes_or_contributes_to Arg1:T67 Arg2:T8	
T69	corrected_chemical 344 384	tumor antigen-derived peptide loaded DCs
R3	treats Arg1:T69 Arg2:T11	
T70	corrected_chemical 494 523	serotonin-reuptake inhibitors
R4	treats Arg1:T70 Arg2:T12	
R5	treats Arg1:T15 Arg2:T16	
R8	treats Arg1:T23 Arg2:T25	
T71	corrected_disease_or_phenotypic_feature 940 957	pituitary tumours
T72	corrected_chemical 875 897	somatostatin analogues
R9	treats Arg1:T72 Arg2:T71	
R10	treats Arg1:T27 Arg2:T71	
T73	corrected_chemical 1233 1246	MYC inhibitor
T75	missed_disease_or_phenotypic_feature 1353 1378	estrogen-dependent tumors
R12	treats Arg1:T41 Arg2:T75	
T77	missed_disease_or_phenotypic_feature 1489 1494	tumor
T79	corrected_chemical 1589 1598;1620 1635	synthetic A2AR antagonist
R11	treats Arg1:T73 Arg2:T40	
R6	causes_or_contributes_to Arg1:T21 Arg2:T22	
T74	corrected_chemical 1612 1659	natural A2AR antagonist 1,3,7-trimethylxanthine
R7	treats Arg1:T79 Arg2:T77	
R13	treats Arg1:T74 Arg2:T77	
R14	treats Arg1:T50 Arg2:T77	
R15	treats Arg1:T49 Arg2:T77	
